ArticleFrontiers in oncology2023

The impact of staging FDG-PET/CT on treatment for stage III NSCLC - an analysis of population-based data from Ontario, Canada.

Craig A Beers et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.